NYSE:ZTSPharmaceuticals
Assessing Zoetis (NYSE:ZTS) Valuation As Higher Value Pet Treatments Offset Softer Vet Visits
Conference spotlight and shifting demand in animal health
Zoetis (ZTS) is set to present at the 2026 KeyBanc Capital Markets Healthcare Virtual Forum on March 17, as investors assess how softer routine vet visits and higher-value treatments are shaping the animal health business.
See our latest analysis for Zoetis.
Despite resilient demand for higher-value treatments, Zoetis shares have been under pressure, with a 30 day share price return of 9.98% and a 1 year total shareholder return of...